Piezosurgical Buccal Plate Repositioning Technique for Horizontal Alveolar Ridge Augmentation

NCT ID: NCT05317039

Last Updated: 2022-04-07

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 18 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2021-08-15
• Study Completion Date: 2022-06-30

Brief Summary

Achieving prosthetically driven implant placement is a highly predictable treatment modality with reliable long-term results. Different surgical procedures have been used as a solution for reconstructing of the alveolar ridge with deficient volume. In the present study we demonstrate a modified alveolar ridge split technique for horizontal alveolar ridge augmentation (buccal plate repositioning technique) using the piezotome surgery. Evaluation of the effect of silica-calcium phosphate nanocomposite (SCPC) graft material versus demineralized freeze dried bone allograft (DFBA) in horizontal alveolar ridge augmentation before implant insertion will be performed.

Conditions

Alveolar Bone Loss

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: DOUBLE

Study Groups

Group A

Group A will be treated with the buccal plate repositioning technique and grafted with SCPC.

Group Type: EXPERIMENTAL

silica-calcium phosphate nanocomposite SCPC

Intervention Type: OTHER

Patients will be treated with the buccal plate repositioning technique and grafted with SCPC then the grafted defect will be covered with a platelet-rich fibrin membrane.

Group B

Group B will be similarly managed and grafted using DFDBA

Group Type: ACTIVE_COMPARATOR

freezed dried bone

Intervention Type: OTHER

Patients will be treated with the buccal plate repositioning technique and grafted using DFDBA. then the grafted defect will be covered with a platelet-rich fibrin membrane.

Interventions

silica-calcium phosphate nanocomposite SCPC

Patients will be treated with the buccal plate repositioning technique and grafted with SCPC then the grafted defect will be covered with a platelet-rich fibrin membrane.

Intervention Type: OTHER

freezed dried bone

Patients will be treated with the buccal plate repositioning technique and grafted using DFDBA. then the grafted defect will be covered with a platelet-rich fibrin membrane.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Patients with horizontal atrophy of the posterior mandible with pristine residual alveolar crest width from 2 to 4 mm.
• Augmented area length in the mesial-distal direction of less than 20 mm.
• Adequate physically healthy condition.

Exclusion Criteria

• A systemic disease that would contraindicate oral surgical treatment.
• Treated patients who had undergone therapy involving radiation
• Patients who had received bone resection as part of an oncological treatment after a bone augmentation procedure.
• Patients are subjected to intravenous and/or oral bisphosphonate therapy after the bone augmentation procedure.

• Minimum Eligible Age: 20 Years
• Maximum Eligible Age: 50 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Hams Hamed Abdelrahman

OTHER

Sponsor Role: lead

Responsible Party

Hams Hamed Abdelrahman

Assistant lecturer of DPH and Clinical statistician

Responsibility Role: SPONSOR_INVESTIGATOR

Locations

Alexandria Faculty of Dentistry

Alexandria, , Egypt

Countries

Egypt

Other Identifiers

Piezosurgery_2021

Identifier Type: -

Identifier Source: org_study_id